MRK

#39
Merck & Co., Inc.
120.22 USD
-0.99%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
119.82
120.35
年范围
73.31
125.14
日变化
-0.99%
每月变动
+4.23%
6个月变化
+40.79%
年变化
+50.24%
前一天收盘价
121.42
开盘价
119.95
买价
卖价
最低价
119.82
High
120.35
交易量
1 109
展开完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 297.23 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
14.46
市销率
4.06
每股股息
3.28
股息收益率 %
3.12

Merck & Company Inc (new)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

新闻